SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Concord Biotech informs about conference call

13 Sep 2023 Evaluate
Concord Biotech has informed that the transcripts of the Earnings call for the quarter ended June 30, 2023 enclosed and available on the website of the company at the following link after sending this letter. Also informed that this transcript and the audio recording of the call, both have been uploaded on its website as follows: https://www.concordbiotech.com/investors

The above information is a part of company’s filings submitted to BSE.

Concord Biotech Share Price

1304.10 -0.80 (-0.06%)
10-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.25
Dr. Reddys Labs. 1245.50
Cipla 1438.75
Zydus Lifesciences 1150.50
Lupin 2496.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: